Enhancing the functional maturity of induced pluripotent stem cell–derived human hepatocytes by controlled presentation of cell–cell interactions in vitro

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Hepatology

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.27621PMID 25421237
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Accurate Prediction of Drug‐Induced Liver Injury Using Stem Cell‐Derived Populations

  2014cited by this paper
• Generation of hepatocyte-like cells from human induced pluripotent stem (iPS) cells by co-culturing embryoid body cells with liver non-parenchymal cell line TWNT-1.

  2014cited by this paper
• Maturation of Induced Pluripotent Stem Cell Derived Hepatocytes by 3D-Culture

  2014cited by this paper
• Pluripotent stem cell-derived hepatocyte-like cells.

  2014cited by this paper
• CellNet: network biology applied to stem cell engineering.

  2014cited by this paper
• Direct reprogramming of human fibroblasts to functional and expandable hepatocytes.

  2014cited by this paper
• Human induced pluripotent stem cells in hepatology: beyond the proof of concept.

  2014cited by this paper
• Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming.

  2014cited by this paper
• Mouse liver repopulation with hepatocytes generated from human fibroblasts

  2014cited by this paper
• Identification of small molecules for human hepatocyte expansion and iPS differentiation

  2013cited by this paper
• Use of micropatterned cocultures to detect compounds that cause drug-induced liver injury in humans.

  2013cited by this paper
• A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax.

  2013cited by this paper
• Vascularized and functional human liver from an iPSC-derived organ bud transplant

  2013cited by this paper
• Hepatocyte nuclear factor 6 activates the transcription of CYP3A4 in hepatocyte-like cells differentiated from human induced pluripotent stem cells.

  2013cited by this paper
• InVERT molding for scalable control of tissue microarchitecture

  2013cited by this paper
• Long‐Term Stability of Primary Rat Hepatocytes in Micropatterned Cocultures

  2013cited by this paper
• Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective

  2013cited by this paper
• 3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing.

  2013cited by this paper
• Human induced pluripotent stem cells and their use in drug discovery for toxicity testing.

  2013cited by this paper
• Highly Efficient Differentiation of Functional Hepatocytes From Human Induced Pluripotent Stem Cells

  2013cited by this paper
• Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME

  2013cited by this paper
• Integrating human pluripotent stem cells into drug development.

  2013cited by this paper
• Rapid generation of mature hepatocyte‐like cells from human induced pluripotent stem cells by an efficient three‐step protocol

  2012cited by this paper
• Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins

  2012cited by this paper
• Organotypic liver culture models: Meeting current challenges in toxicity testing

  2012cited by this paper
• The promotion of hepatic maturation of human pluripotent stem cells in 3D co-culture using type I collagen and Swiss 3T3 cell sheets.

  2012cited by this paper
• Transcription factors controlling responses to toxic chemicals

  2012cited by this paper
• A microfluidic hepatic coculture platform for cell-based drug metabolism studies.

  2010cited by this paper
• Generation of endoderm‐derived human induced pluripotent stem cells from primary hepatocytes

  2010cited by this paper
• Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening.

  2010cited by this paper
• Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development

  2010cited by this paper
• Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells

  2010cited by this paper
• Assessment of a Micropatterned Hepatocyte Coculture System to Generate Major Human Excretory and Circulating Drug Metabolites

  2010cited by this paper
• Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells

  2009cited by this paper
• Microscale culture of human liver cells for drug development

  2008influential reference
• Cellular imaging predictions of clinical drug-induced liver injury.

  2008cited by this paper
• Exploring interactions between rat hepatocytes and nonparenchymal cells using gene expression profiling

  2004cited by this paper
• Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties.

  2003cited by this paper
• Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application

  2001influential reference
• Effect of cell–cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells

  1999cited by this paper
• Liver cell models in in vitro toxicology.

  1998cited by this paper
• Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells.

  1975cited by this paper
• Seria cultivation of strains of human epidemal keratinocytes: the formation keratinizin colonies from single cell is

  1975cited by this paper
• Engineering

  1929cited by this paper
• The FASEB Journal • Research Communication T-cadherin modulates hepatocyte functions in vitro

  year unknowncited by this paper

• Transcriptomic Profile of Directed Differentiation of iPSCs into Hepatocyte-like Cells

  2026cites this paper
• Induced pluripotent stem cell-derived mesenchymal stem cells for modeling and treating metabolic associated fatty liver disease and metabolic associated steatohepatitis: Challenges and opportunities

  2025cites this paper
• Evaluating the synergistic use of advanced liver models and AI for the prediction of drug-induced liver injury

  2025cites this paper
• Developments and Applications of Liver-on-a-Chip Technology—Current Status and Future Prospects

  2025cites this paper
• In vitro liver models for toxicological research.

  2025cites this paper
• Engineered Microtissues to Model the Effects of Dynamic Heterotypic Cell Signaling on iPSC-derived Human Hepatocyte Maturation.

  2025cites this paper
• Standard Protocols for Characterising Primary and In Vitro‐Generated Human Hepatocytes

  2025cites this paper
• Next-generation experimental and computational strategies for drug-drug interaction prophecy.

  2025cites this paper
• Hypoxia and Multilineage Communication in 3D Organoids for Human Disease Modeling

  2025cites this paper
• Biochemical and Biophysical Properties of Extracellular Matrix Nanofibers Modulate iPSC-Derived Human Hepatocyte Maturation.

  2025cites this paper
• Spatial patterning strategies for liver tissue engineering: Biofabrication technologies and applications

  2025cites this paper
• The Applications and Outlook of Organ-on-a-Chip in Pharmacy and Pharmacology (Review)

  2025cites this paper
• Two-dimensionally cultured functional hepatocytes generated from human induced pluripotent stem cell-derived hepatic organoids for pharmaceutical research.

  2025cites this paper
• Complex in vitro models positioned for impact to drug testing in pharma: a review

  2024cites this paper
• Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques

  2024cites this paper
• Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development

  2024cites this paper
• Liver-on-chips for drug discovery and development

  2024cites this paper
• Long-term HBV infection of engineered cultures of induced pluripotent stem cell-derived hepatocytes

  2024influential citation
• A review of current state-of-the-art materiobiology and technological approaches for liver tissue engineering

  2024cites this paper
• Keeping It Organized: Multicompartment Constructs to Mimic Tissue Heterogeneity

  2023cites this paper
• Engineered Platforms for Maturing Pluripotent Stem Cell–Derived Liver Cells for Disease Modeling

  2023cites this paper
• Toxicological applications of human induced pluripotent stem cell-derived hepatocyte-like cells: an updated review.

  2023cites this paper
• Pluripotent Stem Cell-Derived Hepatocyte-like Cells: Induction Methods and Applications

  2023cites this paper
• Multicellular Liver Organoids: Generation and Importance of Diverse Specialized Cellular Components

  2023cites this paper
• In Vitro Assessment of Drug-Induced Liver Injury Using Cell-Based Models: A Review

  2023cites this paper
• Decellularized Liver Nanofibers Enhance and Stabilize the Long‐Term Functions of Primary Human Hepatocytes In Vitro

  2023cites this paper
• Reduced levels of serum EPA and DHA identified in patients with non-small-cell lung cancer using a new rapid validated LC-MS/MS method.

  2023cites this paper
• Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development—Current State-of-the-Art and Future Perspectives

  2022cites this paper
• iPSCs and toxicology

  2022cites this paper
• Leveraging interacting signaling pathways to robustly improve the quality and yield of human pluripotent stem cell-derived hepatoblasts and hepatocytes

  2022cites this paper
• Generation of Complex Syngeneic Liver Organoids from Induced Pluripotent Stem Cells to Model Human Liver Pathophysiology

  2022cites this paper
• Liver Spheroids on Chips as Emerging Platforms for Drug Screening

  2022cites this paper
• Single-cell atlas of human liver development reveals pathways directing hepatic cell fates

  2022cites this paper
• Mera: A scalable high throughput automated micro-physiological system

  2022cites this paper
• Reanalysis of Trichloroethylene and Tetrachloroethylene Metabolism to Glutathione Conjugates Using Human, Rat, and Mouse Liver in Vitro Models to Improve Precision in Risk Characterization

  2022cites this paper
• State-of-the-art liver disease research using liver-on-a-chip

  2022cites this paper
• Construction of a culture protocol for functional bile canaliculi formation to apply human iPS cell-derived hepatocytes for cholestasis evaluation

  2022cites this paper
• Modulation of Human iPSC-derived Hepatocyte Phenotype Via Extracellular Matrix Microarrays.

  2022cites this paper
• Physiologically relevant microsystems to study viral infection in the human liver

  2022cites this paper
• Polygodial, a Sesquiterpene Dialdehyde, Activates Apoptotic Signaling in Castration-Resistant Prostate Cancer Cell Lines by Inducing Oxidative Stress

  2022cites this paper
• Current nonclinical approaches for immune assessments of immuno-oncology biotherapeutics☆.

  2022cites this paper
• Human iPSCs and their uses in developmental toxicology

  2021cites this paper
• Integrated Isogenic Human Induced Pluripotent Stem Cell–Based Liver and Heart Microphysiological Systems Predict Unsafe Drug–Drug Interaction

  2021influential citation
• Plasma-enhanced protein patterning in a microfluidic compartmentalized platform for multi-organs-on-chip: a liver-tumor model

  2021cites this paper
• Elucidating Extracellular Matrix and Stiffness Control of Primary Human Hepatocyte Phenotype via Cell Microarrays

  2021cites this paper
• Generation of Hepatocytes from Human ES/iPS Cells for Regenerative Medicine

  2021cites this paper
• Treatment of α-1 antitrypsin deficiency using hepatic-specified cells derived from human-induced pluripotent stem cells.

  2021cites this paper
• Micropatterned Coculture with 3T3-J2 Fibroblasts Enhances Hepatic Functions and Drug Screening Utility of HepaRG Cells.

  2021cites this paper
• Aquaporin 9 induction in human iPSC‐derived hepatocytes facilitates modeling of ornithine transcarbamylase deficiency

  2021cites this paper
• IPSC-derived 3D human fatty liver models

  2021cites this paper
• Human liver model systems in a dish

  2021cites this paper
• Hepatitis B virus infection modeling using multi-cellular organoids derived from human induced pluripotent stem cells

  2021cites this paper
• Generation of Hepatobiliary Cell Lineages from Human Induced Pluripotent Stem Cells: Applications in Disease Modeling and Drug Screening

  2021influential citation
• Induction and Maturation of Hepatocyte-Like Cells In Vitro: Focus on Technological Advances and Challenges

  2021cites this paper
• Dynamic cell contacts between periportal mesenchyme and ductal epithelium act as a rheostat for liver cell proliferation

  2021cites this paper
• iPSCs for modeling hepatotropic pathogen infections

  2021cites this paper
• Differentiation of human induced pluripotent stem cells to hepatocyte-like cells for toxicological applications

  2021cites this paper
• Latest impact of engineered human liver platforms on drug development

  2021cites this paper
• Radially Aligned Porous Silk Fibroin Scaffolds as Functional Templates for Engineering Human Biomimetic Hepatic Lobules.

  2021cites this paper
• Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine

  2021cites this paper
• Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction

  2021cites this paper
• Cell maturation: Hallmarks, triggers, and manipulation.

  2021cites this paper
• Pluripotent Stem Cell-Derived Human Liver Organoids Enter the Realm of High-Throughput Drug Screening.

  2020cites this paper
• Human biomimetic liver microphysiology systems in drug development and precision medicine

  2020cites this paper
• A 3D Microfluidic Liver Model for High Throughput Compound Toxicity Screening in the OrganoPlate®.

  2020cites this paper
• Organotypic and microphysiological models of liver, gut and kidney for studies of drug metabolism, pharmacokinetics and toxicity.

  2020cites this paper
• HGF Gene Delivering Alginate/Galactosylated Chitosan Sponge Scaffold for Three-Dimensional Coculture of Hepatocytes/3T3 Cells

  2020cites this paper
• Human induced pluripotent stem cell-derived hepatocytes and their culturing methods to maintain liver functions for pharmacokinetics and safety evaluation of pharmaceuticals.

  2020cites this paper
• Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies

  2020cites this paper
• Organoid Medicine in Hepatology

  2020cites this paper
• Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery.

  2020cites this paper
• Advanced microtechnologies for high-throughput screening

  2020cites this paper
• Microscale Collagen and Fibroblast Interactions Enhance Primary Human Hepatocyte Functions in 3-Dimensional Models.

  2020cites this paper
• Stem cell-derived polarized hepatocytes

  2020cites this paper
• Liver stem cells

  2020cites this paper
• PCL-Blended Chitosan Substrates for Patterning the Heterotypic Cell Distribution in an Epithelial and Mesenchymal Coculture System.

  2020cites this paper
• Integrated hiPSC-based liver and heart microphysiological systems predict unsafe drug-drug interaction

  2020cites this paper
• Exploiting CRISPR Cas9 in Three-Dimensional Stem Cell Cultures to Model Disease

  2020cites this paper
• HepaChip-MP - a twenty-four chamber microplate for a continuously perfused liver coculture model.

  2020cites this paper
• Current status of hepatocyte-like cell therapy from stem cells

  2020cites this paper
• A functional long‐term 2D serum‐free human hepatic in vitro system for drug evaluation

  2020cites this paper
• Self‐Organizing Human Induced Pluripotent Stem Cell Hepatocyte 3D Organoids Inform the Biology of the Pleiotropic TRIB1 Gene

  2020cites this paper
• iPSC-derived hepatocytes generated from NASH donors provide a valuable platform for disease modeling and drug discovery

  2020cites this paper
• Advances in Human Induced Pluripotent Stem Cell-Derived Hepatocytes for Use in Toxicity Testing

  2019cites this paper
• Hepatic microphysiological systems: Current and future applications in drug discovery and development

  2019cites this paper
• Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury

  2019cites this paper
• Emerging trends in modeling human liver disease in vitro

  2019cites this paper
• The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro

  2019cites this paper
• Bioprinting for Liver Transplantation

  2019cites this paper
• Microscale Collagen and Fibroblast Interactions Enhance Primary Human Hepatocyte Functions in 3-Dimensional Models

  2019cites this paper
• Stem Cell-Derived Culture Models of Hepatitis E Virus Infection.

  2019cites this paper
• Investigating Induced Pluripotent Stem Cells for Tissue Engineering and Hepatotoxicity Applications

  2019cites this paper
• Intermittent Starvation Extends the Functional Lifetime of Primary Human Hepatocyte Cultures

  2019cites this paper
• Maintenance of Primary Hepatocyte Functions In Vitro by Inhibiting Mechanical Tension-Induced YAP Activation.

  2019cites this paper
• Pharmaceutical Research for Inherited Metabolic Disorders of the Liver Using Human Induced Pluripotent Stem Cell and Genome Editing Technologies.

  2019cites this paper
• Stem-cell derived hepatocyte-like cells for the assessment of drug-induced liver injury.

  2019cites this paper
• Generation of hepatobiliary organoids from human induced pluripotent stem cells.

  2019cites this paper
• Stem-cell based organ-on-a-chip models for diabetes research.

  2019cites this paper
• The Use of Human Pluripotent Stem Cells for Modeling Liver Development and Disease

  2019cites this paper
• The contributions of mesoderm-derived cells in liver development.

  2019cites this paper